Eyüp Başaran
Eyüp Başaran publishes mostly in Organic Chemistry, Molecular Biology and Pharmacology, on topics such as Synthesis and biological activity, Metal complexes synthesis and properties and Cholinesterase and Neurodegenerative Diseases.
- World rank
- #1,525,196 of 7,710,434 ranked researchers
- Rank in Türkiye
- #6,391 of 117,622
- Works
- 66
- Citations
- 945
- Citations per work
- 14.3
What does Eyüp Başaran research?
Eyüp Başaran's work is mostly in Chemistry (39%), Medicine (15%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences3249.1%
- Chemistry2639.1%
- Computer Science46.1%
- Materials Science33.9%
- Everything else1624.6%
- Health Sciences1015.1%
- Medicine1015.1%
- Life Sciences711.2%
- 1Organic Chemistry39% of their works
- 2Molecular Biology11% of their works
- 3Pharmacology8% of their works
- 4Oncology7% of their works
- 5Computational Theory and Mathematics6% of their works
- 6Materials Chemistry4% of their works
Research topics
- Synthesis and biological activity
- Metal complexes synthesis and properties
- Cholinesterase and Neurodegenerative Diseases
- Computational Drug Discovery Methods
- Enzyme function and inhibition
- Synthesis and Characterization of Heterocyclic Compounds
- Free Radicals and Antioxidants
- Phenothiazines and Benzothiazines Synthesis and Activities
Which keywords describe Eyüp Başaran's research?
The keywords of their largest research topics: Anticancer Agents, Medicinal Chemistry, Heterocyclic Compounds, Tubulin Inhibitors, Drug Development, Molecular Docking, Drug Discovery and Antimicrobial.
- Biological Activities
- Antioxidant
- Inhibitors
- Biological Evaluation
- Drug Target Identification
- Cisplatin Resistance
- Acetylcholinesterase
- Antimicrobial
- Molecular Docking
- Tubulin Inhibitors
- Medicinal Chemistry
- Anticancer Agents
- Heterocyclic Compounds
- Drug Development
- Drug Discovery
- Synthesis
- Cholinesterase Inhibitors
- Platinum-Based Drugs
- Virtual Screening
- Carbonic Anhydrases
- Triazines
- Phenolic Compounds
- Phenothiazines
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Anticancer Agents513 topics
- Medicinal Chemistry402 topics
- Heterocyclic Compounds291 topic
- Tubulin Inhibitors291 topic
- Drug Development242 topics
- Molecular Docking212 topics
- Drug Discovery202 topics
- Antimicrobial152 topics
- Synthesis152 topics
- Acetylcholinesterase121 topic
- Cholinesterase Inhibitors121 topic
- Cisplatin Resistance121 topic
- Platinum-Based Drugs121 topic
- Drug Target Identification111 topic
- Virtual Screening111 topic
- Biological Evaluation101 topic
- Carbonic Anhydrases101 topic
- Inhibitors101 topic
- Triazines101 topic
- Antioxidant91 topic
- Phenolic Compounds91 topic
- Biological Activities51 topic
- Phenothiazines51 topic
Where does Eyüp Başaran work?
Eyüp Başaran's main affiliation in the publication record is Batman University, Türkiye.
How many publications and citations does Eyüp Başaran have?
OpenAlex counts 66 works and 945 citations for Eyüp Başaran, an h-index of 19, ranking #1,525,196 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Eyüp Başaran. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.